By Ethan Covey
Secondary bloodstream infections (sBSIs) may pose a significant risk to patients with severe COVID-19, according to a Rutgers University study.
The study is the first to assess the microbiology, risk factors and outcomes among hospitalized patients with sBSIs and severe COVID-19 (Clin Infect Dis [Epub Nov 20, 2020]. doi.org/10.1093/cid/ciaa1748).